Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

AIMS: Biomarkers are increasingly being used in the management of patients with chronic heart failure (HF). Galectin-3 is a recently developed biomarker associated with fibrosis and inflammation, and it may play a role in cardiac remodeling in HF. We determined its prognostic value in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lok, Dirk J. A., Van Der Meer, Peter, de la Porte, Pieta W. Bruggink-André, Lipsic, Erik, Van Wijngaarden, Jan, Hillege, Hans L., van Veldhuisen, Dirk J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858799/
https://www.ncbi.nlm.nih.gov/pubmed/20130888
http://dx.doi.org/10.1007/s00392-010-0125-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858799/
https://www.ncbi.nlm.nih.gov/pubmed/20130888
http://dx.doi.org/10.1007/s00392-010-0125-y

Ejemplares similares